Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2021 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Inventory |
Inventory for the periods presented is as follows:
|
|
|
|
|
|
|
|
|
As of |
|
|
June 30, 2021 |
|
|
December 31, 2020 |
|
Chemical washing solutions |
$ |
6,505 |
|
|
$ |
6,490 |
|
Other |
|
32 |
|
|
|
52 |
|
Total inventory, gross |
|
6,537 |
|
|
|
6,542 |
|
Reserve for obsolescence |
|
(130 |
) |
|
|
(127 |
) |
Total inventory, net |
$ |
6,407 |
|
|
$ |
6,415 |
|
|
| Schedule of Composition of Revenue |
Revenue Recognition
The following table summarizes the composition of the Company’s revenue, net for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Recognized over time |
$ |
122,362 |
|
|
$ |
60,009 |
|
|
$ |
230,630 |
|
|
$ |
144,545 |
|
Recognized at a point in time |
|
73,734 |
|
|
|
36,312 |
|
|
|
140,057 |
|
|
|
98,645 |
|
Other revenue |
|
984 |
|
|
|
5,535 |
|
|
|
1,901 |
|
|
|
13,918 |
|
Revenue, net |
$ |
197,080 |
|
|
$ |
101,856 |
|
|
$ |
372,588 |
|
|
$ |
257,108 |
|
|
| Schedule of Reconciliations of Numerators and Denominators of Basic and Diluted Net (Loss) Income Per Share |
Reconciliations of the numerators and denominators of the basic and diluted net (loss) income per share calculations for the periods presented are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
$ |
(110,300 |
) |
|
$ |
(8,754 |
) |
|
$ |
(85,716 |
) |
|
$ |
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding - basic |
|
264,274,968 |
|
|
|
261,742,515 |
|
|
|
263,218,870 |
|
|
|
261,744,966 |
|
Effect of potentially dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
12,190,606 |
|
Weighted-average common shares outstanding - diluted |
|
264,274,968 |
|
|
|
261,742,515 |
|
|
|
263,218,870 |
|
|
|
273,935,572 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per share - basic |
$ |
(0.42 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.33 |
) |
|
$ |
0.00 |
|
Net (loss) income per share - diluted |
$ |
(0.42 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.33 |
) |
|
$ |
0.00 |
|
|
| Schedule of Antidilutive Shares Excluded from Computation of Diluted (Loss) Net Income Per Share |
The following potentially dilutive shares were excluded from the computation of diluted net (loss) income per share for the periods presented because including them would have been antidilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Stock options |
|
34,522,248 |
|
|
|
2,024,936 |
|
|
|
34,522,248 |
|
|
|
1,916,526 |
|
Restricted stock units |
|
1,632,188 |
|
|
|
- |
|
|
|
1,632,188 |
|
|
|
- |
|
|